1 Brzustewicz E,Bryl E. The role of cytokines in the pathogenesis of rheumatoid arthritis Practical and potential application of cytokines as biomarkers and targets of personalized therapy[J]. Cytokine,2015,76(2):527-536. 2 Furst DE,Emery P. Rheumatoid arthritis pathophysiology:update on emerging cytokine and cytokine-associated cell targets[J]. Rheumatology (Oxford),2014,53(9):1560-1569. 3 Burska A,Boissinot M,Ponchel F. Cytokines as biomarkers in rheumatoid arthritis[J]. Mediators Inflamm,2014,2014(2):e545493. 4 Nold MF,Nold-Petry CA,Zepp JA,et al. IL-37 is a fundamental inhibitor of innate immunity[J]. Nat Immunol,2010,11(11):1014-1022. 5 Wan ZY,Sun Z,Song F,et al Downregulated interleukin 37 expression associated with aggravation of intervertebral disc degeneration[J]. Int J Clin Exp Pathol,2014,7(2):656-662. 6 Li C,Zhao P,Sun X,et al. Elevated levels of cerebrospinal fluid and plasma interleukin-37 in patients with Guilla-Barre syndrome[J]. Mediators Inflamm,2013,2013(5):e639712. 7 Ye L,Ji L,Wen Z,et al. IL-37 inhibits the production of inflammatory cytokines in peripheral blood mononuclear cells of patients with systemic lupus erythematosus:its correlation with disease activity[J]. J Transl Med,2014,12(1):69. 8 Zhao PW,Jiang Wang L,et al. Plasma levels of IL-37 and correlation with TNF-alpha,IL-17A,and disease activity during DMARD treatment of rheumatoid arthritis[J]. PLoS One,2014,9(5):e95346. 9 Xia T,Zheng XF,Qian BH,et al. Plasma Interleukin-37 Is Elevated in Patients with Rheumatoid Arthritis:Its Correlation with Disease Activity and Th1/Th2/Th17-Related Cytokines[J]. Dis Markers,2015,2015(5):e795043. 10 Imaeda H,Takahashi K,Fujimoto T,et al. Epithelial expression of interleukin-37b in inflammatory bowel disease[J]. Clin Exp Immunol,2013,172(3):410-416. 11 Bulau AM,Fink M,Maucksch C,et al. In vivo expression of interleukin-37 reduces local and systemic inflammation in concanavalin A-induced hepatitis[J]. Scientific World Journal,2011,11(4):2480-2490. 12 Sakai N,Van Sweringen HL,Belizaire RM,et al. Interleukin-37 reduces liver inflammatory injury via effects on hepatocytes and non-parenchymal cells[J]. J Gastroenterol Hepatol,2012,27(10):1609-1616. 13 Zeng M,Dang W,Chen B,et al. IL-37 inhibits the production of pro-inflammatory cytokines in MSU crystal-induced inflammatory response[J]. Clin Rheumatol,2016,35(9):2251-2258. 14 McNamee EN,Masterson JC,Jedlicka P,et al. Interleukin 37 expression protects mice from colitis[J]. Proc Natl Acad Sci U S A,2011,108(40):16711-16716. |